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Uncoupling protein 1 (UCP1) catalyzes fatty acid-activated, purine
nucleotide-sensitive proton leak across the mitochondrial inner
membrane of brown adipose tissue to produce heat, and could
help combat obesity and metabolic disease in humans. Studies
over the last 30 years conclude that the protein is a dimer, binding
one nucleotide molecule per two proteins, and unlike the
related mitochondrial ADP/ATP carrier, does not bind cardiolipin.
Here, we have developed novel methods to purify milligram
amounts of UCP1 from native sources by using covalent chroma-
tography that, unlike past methods, allows the protein to be pre-
pared in defined conditions, free of excess detergent and lipid.
Assessment of purified preparations by TLC reveal that UCP1 re-
tains tightly bound cardiolipin, with a lipid phosphorus content
equating to three molecules per protein, like the ADP/ATP carrier.
Cardiolipin stabilizes UCP1, as demonstrated by reconstitution ex-
periments and thermostability assays, indicating that the lipid has
an integral role in the functioning of the protein, similar to other
mitochondrial carriers. Furthermore, we find that UCP1 is not di-
meric but monomeric, as indicated by size exclusion analysis, and
has a ligand titration profile in isothermal calorimetric measure-
ments that clearly shows that one nucleotide binds per mono-
mer. These findings reveal the fundamental composition of UCP1,
which is essential for understanding the mechanism of the protein.
Our assessment of the properties of UCP1 indicate that it is not
unique among mitochondrial carriers and so is likely to use a com-
mon exchange mechanism in its primary function in brown adi-
pose tissue mitochondria.
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Brown adipose tissue oxidizes fatty acids to produce heat forthermoregulation in the cold and is present in adult humans,
where it holds promise in combating obesity (1, 2). Human
brown fat depots correlate with leanness (3, 4) and, in mice,
thermogenesis by brown fat has been shown to clear blood tri-
glycerides and dispose of blood glucose, reducing metabolic
disease (5). Thermogenesis by brown adipose tissue depends on
uncoupling protein 1 (UCP1), a 33-kDa mitochondrial carrier
protein that, when activated, transports protons across the mi-
tochondrial inner membrane, decoupling electron transfer from
ATP synthesis to dissipate the protonmotive force as heat. During
the adrenergic stimulation of brown adipocytes (e.g., due to cold
exposure), long chain fatty acids released from lipid droplets ac-
tivate UCP1, overcoming the inhibition of the protein by cytosolic
purine nucleotides, to induce thermogenesis (6). Therapeutically
activating UCP1 directly, without the need for physiological stimuli,
could provide treatments for metabolic disease (6, 7).
The mechanism of proton conductance by UCP1 and the in-
terplay that occurs between regulators is debated (refs. 8 and 9).
Evidence largely from liposome studies has led to the proposals
that fatty acid anions act as either cofactors, providing proton-
binding sites in a transport channel within the protein (10), or
transport substrates, which are exported by UCP1 and flip back
across the inner membrane in a protonated state (11). Alterna-
tively, patch-clamp studies with mitochondrial inner membranes
suggest that either protonated or deprotonated fatty acid species
can be transported by UCP1, which remain bound to the protein
in the transport cycle to give a net proton transfer (9). During
activation, fatty acids may compete with nucleotide binding directly,
or indirectly through changes in the protein, as indicated by ex-
periments with isolated mitochondria (12, 13). Claims of the in-
volvement of other metabolites (e.g., ubiquinone-10 or 4-hydroxy-
2-nonenal) in UCP1 activation have largely been refuted (14, 15).
For many years, there has been a general consensus on the
fundamental composition of UCP1. Following the observation
that one nucleotide binds to two proteins (16), UCP1 was be-
lieved to be a dimer. This notion was supported by analytical
ultracentrifugation (17), nucleotide binding (18–21), and protein
cross-linking studies (18, 22), as well as many reports indicating
that the related mitochondrial ADP/ATP carrier is dimeric too
(see ref. 23 and references therein). Distinct from other carriers,
however, UCP1 was found to function independently of car-
diolipin. This mitochondrial lipid enhances the activity of many
carriers (24) and can be observed bound to the ADP/ATP carrier
in the available atomic structures (25–27). Measurements of 31P
NMR have indicated that purified UCP1 preparations do not
contain bound cardiolipin (28), in contrast to the three molecules
reported to bind per ADP/ATP carrier (29), and reconstitution
studies have indicated that the lipid is not required for UCP1 ac-
tivity (e.g., refs. 30 and 31) but may alter the affinity of the protein
for purine nucleotides (28).
Significance
Uncoupling protein 1 (UCP1) is a mitochondrial carrier protein
responsible for thermogenesis in brown adipose tissue, and a
putative therapeutic target for the treatment of obesity and
related diseases. It is widely accepted that the protein is di-
meric and regulated by binding one nucleotide per dimer, and
unlike other mitochondrial carriers, functions independently of
the lipid cardiolipin. Here, we have developed novel methods
to purify UCP1 from native sources, and demonstrate that the
protein is in fact monomeric, binding nucleotide in a 1:1 stoi-
chiometry. Each protein also binds three cardiolipin molecules,
which confer stability. These findings put in place the true
composition of UCP1, overturning a paradigm, which is crucial
to resolve the controversial mechanism of this important
membrane protein.
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In recent years, several studies have demonstrated that the
mitochondrial ADP/ATP carrier is monomeric, not dimeric (32–
36), which raises questions on the oligomeric state of UCP1.
Resolving the basic functional unit of UCP1 is paramount for
understanding its mechanism. Here, we have developed novel
methods to purify UCP1 from native sources, which have allowed
us to reach new conclusions on the fundamental properties of
the protein.
Results
Purification of UCP1 Using Covalent Chromatography. The recombi-
nant expression of UCP1 in yeast or Escherichia coli can produce
artifacts associated with misfolded protein (e.g., refs. 37 and 38),
and so native material is essential to gain reliable information on
the protein. Native UCP1 has typically been isolated from the
brown adipose tissue of rodents, although we have found that
newborn lambs are a rich and available source of the tissue.
Established purification methods rely on the passage of Triton
X-100 solubilized UCP1 through hydroxyapatite media (nega-
tive chromatography) (18), where excess detergent and endog-
enous lipid elute with the isolated protein and can interfere with
downstream investigations. To avoid these issues, we have de-
veloped new procedures to purify native UCP1, exploiting the
new maltose neopentyl glycol class of detergents (39) and a
conserved cysteine residue at the C terminus of the protein, which
exposes a reactive thiol group (22) (Fig. S1). In the method
(summarized in Fig. 1A), UCP1 is first enriched through the
removal of soluble and nonintegral membrane proteins by alkali
treatment of mitochondria, and solubilized in decyl maltose
neopentyl glycol (10MNG) detergent, before being desalted and
passed through S and Q ion-exchange resins to remove the ma-
jority of protein contaminants. UCP1 is then covalently bound to a
thiol propyl Sepharose (TPS) resin and washed, before being
eluted off by reducing agent (DTT) in a defined buffer (see the
gel profile of an example purification; Fig. 1B). We found that
this strategy allowed UCP1 to be purified to homogeneity (Fig. 1D),
free of ADP/ATP carrier (Fig. S2), with yields similar to those
obtained with hydroxyapatite (∼2 mg of UCP1 per 100 mg of
starting mitochondria). The TPS-immobilization step could also
be applied to hydroxyapatite preparations to facilitate buffer
exchange and washing of the protein (Fig. 1 C and D).
When reconstituted into phosphatidylcholine liposomes,
UCP1 prepared by our new methods exhibited high proton
conductance rates in the presence of oleic acid upon induction
of a membrane potential with valinomycin, comparable to UCP1
prepared by conventional hydroxyapatite methods (Fig. 2A). The
activity was almost fully inhibited by 40 μM GDP in the assay
buffer, where subsequent carbonyl cyanide 3-chlorophenylhydrazone
(CCCP) additions confirmed that the total proton transfer ca-
pacity of the liposome system had not changed. The high proton
conductance activity and nucleotide sensitivity demonstrate that
the protein is intact and active with a predominantly externally
oriented GDP binding site in liposomes. In the absence of in-
terfering substances, such as Triton X-100, our UCP1 prepara-
tions were suitable for assessment by far UV circular dichroism,
where a reliable signal down to ∼185 nm could be obtained (Fig.
2B and Fig. S3). The profile revealed a strong alpha helical
signature in the protein, in line with structural data for the re-
lated ADP/ATP carrier (25–27), with a positive band at 193 nm
and negative bands at 209 nm and 220 nm. Various effectors did
relatively little to the profile (Fig. S3A). However, SDS de-
creased the amplitude of the signal, particularly at ∼193 nm
(from 42,000 to 23,000 deg·cm2·dmol−1; Fig. 2B), consistent with
the denaturation of UCP1 to an unfolded state, retaining sig-
nificant secondary structural elements.
Importantly, during purification using TPS resin, we found
that the wash buffers required supplementing with lipid
(0.05 mg/mL cardiolipin or phosphatidylcholine), because lower
yields were observed when UCP1 was washed in buffer alone,
indicating that the protein becomes unstable. As an alternative
to added lipid, we included GDP in the wash buffer to stabilize
UCP1. The quantification of lipid phosphorus in various prep-
arations confirmed that the total lipid was substantially lower
where UCP1 had been bound to TPS and washed (Table 1), even
with lipid supplementation. Where only GDP had been used in
the absence of added lipid, however, we found that UCP1 still
retained ∼6 moles of endogenous lipid phosphorus per mole of
UCP1, despite extensive washing (Table 1).
Cardiolipin Copurifies with UCP1 and Is Required for Stability. To
identify the lipids retained by UCP1, we separated solvent extracts
of the purified protein by TLC. Because mitochondrial lipids from
brown adipose tissue are predominantly unsaturated (40), a
charring detection method was used that is insensitive to satu-
rated lipids (such as those used for buffer supplementation; Fig.
3A) to identify the endogenous lipids in the UCP1 preparations.
Fig. 1. Purification of native UCP1. Scheme of the procedure (A) and Coo-
massie-stained gel profile (B) of UCP1 purification by alkali wash treatment,
passage through cation (S) and anion (Q) exchange media and binding to
TPS resin (T). Ten micrograms of enriched membranes and equivalent frac-
tions (by volume) of sample from subsequent steps in the procedure were
loaded on to gels. (C) Equivalent profile of UCP1 purification using hy-
droxyapatite (HA) combined with TPS binding. (D) Coomassie-stained gel
of final UCP1 samples (2 μg of protein per lane) purified as in B (lane 1) or
C with hydroxyapatite alone (lane 2), or with hydroxyapatite and binding to
TPS resin (lane 3). Note, buffers were supplemented with 18:1 cardiolipin
during covalent chromatography (Methods).
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The results show that UCP1 almost exclusively retained car-
diolipin (with only a minor amount of phosphatidylcholine), even
when washed in purification buffer with added 14:0 cardiolipin
or 14:0 phosphatidylcholine (Fig. 3B). Similar washes in the
harsher detergent decyl maltoside (10M) did not facilitate car-
diolipin exchange even when the washes were extended (Fig. 3 C
and D, respectively), indicating that the endogenous lipid is
tightly bound to the protein (note, endogenous phosphatidyl-
choline could not be assessed because of interference by 10M).
Even so, following reconstitution into pure phosphatidylcholine
liposomes, UCP1 activity displayed a striking dependence on
the cardiolipin that had been added to the wash buffer during
purification, but only with the harsher 10M wash (Fig. 2C).
GDP-sensitive rates of proton conductance were similar for
protein that had been washed in 10MNG with either 14:0 car-
diolipin or 14:0 phosphatidylcholine present, or 10M detergent
with 14:0 cardiolipin present, but no activity was measured with
protein that had been washed in 10M with phosphatidylcholine.
The 10M wash may partially remove endogenous cardiolipin
that is important for UCP1 activity, which can only be replaced
by added 14:0 cardiolipin. Immunoblots of the final gel-filtered
liposome fractions reveal that losses in activity relate to a com-
plete loss of UCP1 incorporation into the liposomes rather than a
decrease in specific activity of the protein (Fig. 2C), suggest-
ing that cardiolipin is required for protein stability during
reconstitution.
We tested the stability of purified UCP1 directly with a ther-
mostability assay that monitors protein unfolding with the thiol-
reactive dye N-[4-(7-diethylamino-4-methyl-3-coumarinyl) phe-
nyl]maleimide (CPM). CPM reacts with protein-buried cysteine
residues as they become solvent exposed due to thermal de-
naturation to give a fluorescent adduct (41, 42). In tests, ovine
UCP1 exhibited a background fluorescence (Fig. 2D), indicating
that at least one of the nine cysteine residues is solvent exposed
in the native state. In each condition, the signal transitioned to a
higher plateau with an increase in temperature as the protein
unfolded, allowing an apparent denaturation or “melt” temper-
ature (Tm) to be determined from the derivative of the profile.
UCP1 proved to be highly unstable when purified and assessed in
the absence of lipid or nucleotide, exhibiting an apparent Tm of
27.0 ± 0.7 °C (Fig. 2 D and E). When purified and assessed in the
presence of phosphatidylcholine or cardiolipin, however, the
apparent Tm was 46.4 ± 0.1 °C and 52.8 ± 0.6 °C, respectively
(∼20 and ∼25 °C higher). GDP in the assay buffer increased the
apparent Tm of UCP1 by ∼24 °C and further improved the sta-
bility of UCP1 in the presence of lipids as well (Fig. 2E). Lipid
supplementation, particularly cardiolipin, may reduce the dis-
sociation of endogenous-bound cardiolipin during the assay,
which, in turn, stabilizes the protein.
UCP1 Is Monomeric and Binds Nucleotide in a 1:1 Stoichiometry. To
determine the oligomeric state of UCP1, we assessed the size of
the purified protein by size exclusion chromatography. In 10MNG
supplemented with 18:1 cardiolipin, UCP1 eluted with a major
peak corresponding to a molecular mass of ∼127 kDa when
calibrated with molecular weight markers (Fig. 4A). Minor
amounts of protein at higher molecular masses (see gel profile
of the eluted fractions) were consistent with various oligomers
associated with generic aggregation in detergent, as observed
for the ADP/ATP carrier (35, 36). Quantification of the asso-
ciated detergent and lipid present in the UCP1 peak fraction
revealed that 2.3 g of detergent and 0.5 g of lipid per g of
protein were bound. This amount equated to a detergent and
lipid contribution of 77 kDa and 16 kDa, respectively, to the
127-kDa protein-detergent micelle, leaving 34 kDa of protein,
which correlates well with the calculated mass of a single UCP1
polypeptide (33 kDa; Fig. 4B). In contrast to the prevailing
view, therefore, UCP1 is monomeric, in line with recent find-
ings for the ADP/ATP carrier (32–36).
Fig. 2. Integrity of purified UCP1. (A) Proton uptake by liposomes (pure
phosphatidylcholine) reconstituted with UCP1 purified by ion exchange/co-
valent chromatography (i) or conventional hydroxyapatite chromatography
(ii). (B) CD spectra of native UCP1. Scans are of 0.6 mg/mL purified protein in
buffer (10 mM Tris·HCl pH 7.4) containing 0.05% 10MNG in the absence
(solid line) or presence of 0.5% or 1.0% SDS (dashed and dotted lines, re-
spectively) at 10 °C. See Fig. S3A for other conditions and S3B for corre-
sponding PMT dynode voltages. (C) Proton uptake rates (nmol/min) and
relative UCP1 content (immunoblot) of liposomes reconstituted with UCP1
protein that had been washed in 10MNG or 10M detergent supplemented
with 14:0 cardiolipin (CL) or 14:0 phosphatidylcholine (PC) during purifica-
tion by ion exchange/covalent chromatography, as indicated (Methods). All
proton uptake assays were in the presence of 200 μM oleic acid (1.6 mM
methyl-β-cyclodextrin), ± 40 μM GDP, with rates driven by a membrane po-
tential (positive outside) induced by addition of 2.5 μM valinomycin to li-
posomes with 100 mM internal and 1 mM external potassium present. Rates
are averages (± SD) of three independent experiments. (D and E) The rela-
tive thermal stability of UCP1 purified by ion exchange/covalent chromatog-
raphy in the absence or presence of lipid. Protein unfolding was monitored by
the fluorescence of CPM-adduct formation at cysteine residues as they become
solvent exposed due to thermal denaturation. Representative traces (D) and
average (± SD; triplicate measurements) melt temperatures (E) of native UCP1
in assay buffer containing 10MNG, supplemented with lipid, as indicated, ± 2 mM
GDP. Unless stated otherwise, UCP1 was purified by covalent chromatogra-
phy in buffer supplemented with 18:1 cardiolipin.
Table 1. The content of phosphorus associated with
phospholipids in UCP1 preparations
Purification
method Buffer supplement
Lipid phosphorus:UCP1,
mol:mol
HA — 115.2 ±9.3
HA/T 0.05 mg/mL CL 24.2 ±0.6
S/Q/T 0.05 mg/mL CL 21.8 ±2.2
S/Q/T 0.8 mM GDP 6.2* ±2.0
*Corrected for GDP phosphorus.
See Fig. 1 for purification method abbreviations; CL, 14:0 cardiolipin.
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Original observations with isolated UCP1 indicated that one
nucleotide is bound per two UCP1 (16). To obtain an accurate
measure of the binding stoichiometry, we used isothermal titration
calorimetry, which is well suited to assessing nucleotide–protein in-
teractions. Purified UCP1, quantified by amino acid analysis, was ti-
trated with known concentrations of GDP (e253 = 13,700 M
−1·cm−1),
and the enthalpy changes associated with ligand binding were
recorded (Fig. 4C). Importantly, the assay buffer used was kept
free of the many anions that may compete with nucleotide binding
to UCP1 (e.g., ref. 43). The resulting isotherms were fitted with an
appropriate binding model (Fig. 4C), which revealed that 1.1 GDP
molecules bind per UCP1, as indicated by the ligand/protein
molar ratio at the center of the isotherm, with a KD of 46 ± 3 nM
in the absence of interfering salts (determined from 1/slope). This
stoichiometry is in clear contrast to the original experimental work
that led to the dimer premise (16).
Discussion
Despite intensive research, there are many inconsistencies and
controversies on the nature of UCP1 activity. These problems
may in part relate to the susceptibility of the protein to produce
artifacts in recombinant systems, as well as the general difficul-
ties associated with studying membrane proteins in isolation.
Traditionally, native UCP1 has been purified in polyoxyethylene
detergents (e.g., Triton X-100) by negative chromatography us-
ing hydroxyapatite media, and a consensus on the composition of
the protein was established. The protein was understood to be
dimeric and, unlike other carriers, operate without binding car-
diolipin. Through the development of improved purification
methods, however, we have found that these conclusions on the
fundamental properties of the protein are incorrect. UCP1 is
monomeric and tightly binds cardiolipin, which is required for
its stability.
In the absence of lipid supplementation, we found that ap-
proximately six moles of lipid phosphorus are associated with
UCP1, almost all in the form of cardiolipin. This stoichiometry
equates to approximately three molecules of cardiolipin bound
to each UCP1, the same ratio as observed for the mitochondrial
ADP/ATP carrier (29). Crystal structures of the ADP/ATP car-
rier show that cardiolipin binds at three positions, consistent with
the threefold pseudosymmetry of the structure, where each lipid
head group links two domains toward the matrix side of the
protein (25–27). A recent analysis of the molecular interactions
involved indicate that the negatively charged phosphate groups
in cardiolipin interact electrostatically with the positive pole of
the helix dipoles of the even-numbered and matrix helices (27),
and form hydrogen bonds with amide groups of the protein
backbone. Residues from the [YF]xG and [YWF][KR]G motifs
(present in each of the three repeat domains) play a key role in
the architecture of the binding site. The glycine residues of the
Fig. 4. Determining the oligomeric state and nucleotide binding stoichi-
ometry of purified UCP1. (A) Assessment of the molecular mass of UCP1 in
0.05% 10MNG supplemented with 0.05 mg/mL 18:1 cardiolipin by exclu-
sion chromatography. (Inset Right) Calibration of the size exclusion par-
tition coefficient (Kav) to the molecular mass of a protein by using the
markers carbonic anhydrase (29 kDa), ovalbumin (44 kDa), conalbumin
(75 kDa), aldolase (158 kDa), and ferritin (440 kDa). (Inset Top) Coomassie-
stained SDS gel of eluted fractions, aligned accordingly. (B) The mass
composition of the major peak eluted during size exclusion chromatog-
raphy. Protein, detergent, and phospholipid were quantified as described
in SI Materials and Methods. (C ) Isothermal titration calorimetry of puri-
fied UCP1 with GDP. The enthalpy changes associated with the titration of
GDP into UCP1 at 4 °C (Top), and corresponding isotherms fitted to a one-
site binding model with ΔH, Kd, and stoichiometry as fitting parameters
(Bottom). (Inset) Average data (± SD) from three independent titration
experiments (Fig. S4). UCP1 protein was purified by ion exchange, covalent
and size exclusion chromatography, and experiments carried out in ITC
buffer (50 mM cacodylate (TEA) pH 6.0, 0.01% 10MNG, 0.01% tetraoleoyl
cardiolipin).
Fig. 3. Endogenous cardiolipin copurifies with UCP1. TLC of phospholipid/
detergent standards (A) and lipid extracts from purified UCP1 after immo-
bilizing and washing the protein on TPS resin (B–D). (A) The saturated and
unsaturated phospholipid standards (2 μg of each) are phosphatidylcholine
(PC), phosphatidylethanolamine (PE), phosphatidic acid (PA), cardiolipin (CL),
and beef heart cardiolipin (BHCL), and the detergent standards (80 μg of
each) are decyl maltoside neopentyl glycol (10MNG) and decyl maltoside
(10M). Note, saturated lipids, such as those used for supplementation during
UCP1 purification, are not detected in the assay. (B–D) The lipids associated
with UCP1 following ion exchange/covalent chromatography purification
with 100-mL washes in 0.05% 10MNG detergent (B) or 0.2% 10M detergent
(C), or extended 300 mL washes in 0.2% 10M detergent (D), supplemented
with 2 mM GDP, 14:0 phosphatidylcholine or 14:0 cardiolipin to stabilize the
protein, as indicated.
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two motifs act as helix breakers, whereas the aromatic residues
make hydrophobic contacts with the lipid acyl chains (25–27).
Crucially, these motifs are present in UCP1 (although the glycine
at position 248 is replaced by serine, also a helix breaker), in-
dicating that UCP1 most likely binds cardiolipin in a similar
manner as the mitochondrial ADP/ATP carrier. The observed
stabilizing effect of cardiolipin and other lipids here is most likely
achieved by increasing the size of the supporting detergent mi-
celle (42), which, in turn, may impact on the behavior of the
tightly bound species.
UCP1, which has a molecular mass of 33 kDa, migrated as an
∼127-kDa species in size exclusion chromatography, yet the
carrier is monomeric after accounting for the contributions of
the detergent and lipid. Similar observations were made with the
mitochondrial ADP/ATP carrier where the apparent size of the
monomer varied dramatically with different detergents because
of the size of the associated micelle (34). The apparent size of
the ADP/ATP carrier was also heavily influenced by lipids, which
increased the Stokes radius of the associated detergent micelle,
giving a considerable increase in overall mass (44). Previous es-
timates of the mass of UCP1 in Triton X-100 detergent (∼180
kDa; ref. 17) may not have been suitably adjusted for the high
amount of detergent and lipid present following purification
using hydroxyapatite. It is likely, therefore, that the protein was
monomeric in past work too.
Nucleotides were reported to bind to UCP1 in a 1:2 stoichiom-
etry, supporting the idea that the protein forms dimers. However,
accurate isothermal calorimetry titrations unambiguously demon-
strate that GDP binds in a 1:1 stoichiometry. Past studies typically
relied on a modified Lowry method to quantify protein (16, 18–21),
which is likely to have overestimated protein amounts in the
presence of high concentrations of Triton X-100 (45). Our data
support a simple model where each UCP1 monomer is capable
of binding a single nucleotide. In line with this model, past
observations with UCP1 provide clues on the way that nucleotides
interact with the protein. Binding occurs in a similar manner to
carboxy-atractyloside inhibition of the ADP/ATP carrier, where
the nucleotide binds to a central substrate-binding site in UCP1
from the cytosolic side. Note that nucleotides increase the stability
(e.g., Fig. 2D) and resistance to trypsinolysis (13) of UCP1, similar
to the effects of carboxy-atractyloside on the ADP/ATP carrier
(46), indicating that inhibition may occur in the cytoplasmic state
of the protein. The mutagenesis of three highly conserved arginine
residues in UCP1 (related by threefold pseudosymmetry in the
monomer) abolishes nucleotide binding (47, 48). These residues
are the contact points of the substrate-binding site in other mi-
tochondrial carrier proteins where they are well placed to engage
in electrostatic interactions with the phosphate moiety of nucle-
otides (49, 50). An interaction in this region of the protein would
be consistent with the loss of nucleotide binding associated with
the covalent modification of Glu-190 in UCP1 by N-ethyl-5-phe-
nylisoxazolium 3′-sulfonate (Woodward’s Reagent K) (51). This
conserved residue is involved in the pH regulation of nucleotide
binding and is predicted to face the central cavity toward the cy-
tosolic side of the UCP1 monomer, where adduct formation would
obstruct access to the central binding site. Our results infer that
nucleotide regulation of UCP1 occurs through a relatively simple
binding process, without the complication of dimer cross-talk
(e.g., ref. 10), and provide a core structural basis for future in-
vestigations. The development of compounds that compete with
nucleotides at the binding site without inhibiting proton flux may
provide therapeutic means to switch thermogenesis on in brown
fat artificially.
Our findings have implications on the mechanism of UCP1,
which is the subject of ongoing debate. UCP1 is monomeric and
dependent on cardiolipin, and so is more similar to other mito-
chondrial carriers than previously thought. Amino acid sequence
analysis indicates that UCP1 has retained all of the key residues
for carrier function, such as those involved in the formation of
two salt bridge networks that gate access to a central substrate-
binding site in the carrier transport cycle (27, 50), as well as those
involved in the binding of cardiolipin. These observations put
considerable constraint on how the protein is likely to operate
and implies that the primary function of UCP1 relies on a con-
ventional carrier transport mechanism. Based on symmetry analysis
across carriers, uncoupling proteins were predicted to transport
small carboxylic or keto acids via a strict exchange process (49, 50).
In line with this notion, recombinant UCP2 was shown to exchange
C4 metabolites, such as aspartate, malate, malonate, and oxa-
loacetate (52). However, recombinant UCP1 did not transport these
substrates in parallel tests. The properties of the protein described
here would favor the only mechanistic model of those currently
debated that can be described by a conventional carrier exchange
mechanism. In the “shuttling model” (9), UCP1 is effectively a fatty
acid/fatty acid anion “exchanger,” in which long chain fatty acids are
transported in either a protonated or nonprotonated state but re-
main bound to the protein/membrane because of their hydropho-
bicity, leading to a net proton transport only.
Through the use of new purification procedures, we have
uncovered the true composition of native UCP1. As such, there
is now robust experimental evidence demonstrating that the two
most studied mitochondrial carriers, UCP1 and the ADP/ATP
carrier, are monomeric and bind cardiolipin, which sets a prece-
dent for the rest of the protein family.
Methods
Purification of UCP1 by NewMethods.Mitochondria were isolated from brown
adipose tissue of newborn lambs (see SI Materials and Methods) and the
membranes enriched by alkaline treatment (53). Mitochondria (∼600 mg of
protein) were suspended in 360 mL of alkaline lysis buffer (100 mM Na2CO3
pH 11.5, 1 mM EDTA) and incubated for 30 min with gentle stirring at 4 °C.
Membranes were pelleted by centrifugation (200,000 × g for 40 min) and
resuspended by homogenization in 360 mL of membrane wash buffer [20 mM
Tris·HCl pH 7.4, 1 mM EDTA, 10% (vol/vol) glycerol]. The suspension was
recentrifuged and the pellets resuspended in membrane storage buffer
[10 mM Tris·HCl pH 7.4, 10% (vol/vol) glycerol] by using a small glass ho-
mogenizer to a final protein concentration of ∼20 mg/mL before storage in
liquid nitrogen. Enriched membranes (50–60 mg) were thawed, harvested by
centrifugation (250,000 × g for 15 min) and suspended in solubilization
buffer [3–4% (wt/vol) 10MNG, 300 mM NaCl, 20 mM Tris pH 8.0 with Com-
plete protease inhibitor minus EDTA] to ∼10 mg/mL protein. The sample was
gently agitated for 1 h (<10 °C), centrifuged (250,000 × g for 20 min) to
remove insoluble material, and the supernatant desalted using PD-10 col-
umns (GE Healthcare). UCP1 was purified by passage through a Vivaspin S
Maxi H cation exchange spin column (Sartorius), supplemented with 50–80mM
NaCl and further purified by passage through a Vivapure Q Maxi H anion
exchange spin column. The purified protein was supplemented with
150 mM NaCl and 1 mM EDTA and mixed with thiopropyl Sepharose 6B
(Sigma; 100–150 mg dry per mg of UCP1, prerinsed in deoxygenated water)
for 1 h with gentle agitation in an empty PD-10 column (<10 °C). The column
was packed and eluted by gravity flow and washed with 50–75 mL per mg of
protein of deoxygenated TPS buffer (50 mM Tris·HCl pH 8.0, 150 mM NaCl,
1 mM EDTA) containing 0.05% 10MNG or 0.2% 10M, ±0.1 g lipid per g de-
tergent (the flow rate was ∼5 mL/min). The damp resin was mixed with 2.5 mL
TPS buffer containing 150 mM DTT for 15 min (<10 °C) and the column was
centrifuged (500 × g, 5 min) to recover UCP1. The eluate was exchanged
into storage buffer (10 mM Tris·HCl pH 7.4, 0.01% 10MNG or 0.1% 10M,
±0.1 g lipid per g detergent) by using a PD-10 desalting column and con-
centrated to 5–8 mg/mL using a centrifugal device (50K MWCO Amicon
Ultra) before storage in liquid nitrogen. Details of the other methods used in
this study are given in SI Materials and Methods.
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